Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
Holding CAH?
Track your performance easily
CAH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$93.17 - $126.23
Previous CloseN/A
Volume818.36K
Average Volume (3M)2.11M
Market Cap
$30.02B
Enterprise Value$29.38B
Total Cash (Recent Filing)$6.88B
Total Debt (Recent Filing)$9.07B
Price to Earnings (P/E)24.2
Beta0.48
Next Earnings
Jan 30, 2025EPS Estimate
1.76Last Dividend Ex-Date
Jan 02, 2025Dividend Yield1.62%
Share Statistics
EPS (TTM)5.15
Shares Outstanding242,010,500
10 Day Avg. Volume2,169,490
30 Day Avg. Volume2,109,448
Standard Deviation0.08
R-Squared0.19
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.13
Price to Cash Flow (P/CF)-4.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue0.13
Enterprise Value/Gross Profit3.96
Enterprise Value/Ebitda10.34
Forecast
1Y Price Target
$135.54Price Target Upside6.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Cardinal Health News
PremiumCompany Announcements
Cardinal Health Raises 2025 Earnings Forecast ExpectationsBulls Say, Bears Say
Bulls Say
Financial PerformanceCardinal Health expects adjusted EPS toward the high end of its previous range, driven by strong demand for brand, specialty, and generic drugs.
Growth PotentialNew customers, strong utilization trends, and recent M&A into specialty services should allow CAH to see adjusted EPS growth above current expectations.
Market PositionThe distributor group continues to benefit from broad-based utilization strength, expected to persist throughout future periods.
Bears Say
Debt And Financial HealthRecent acquisitions will add $5 billion of net debt to the balance sheet, raising concerns about financial stability despite a commitment to deleveraging.
Profitability And GrowthIndustry pricing headwinds could partially offset profit growth, indicating potential challenges in maintaining profitability.
Segment PerformanceThe Global Medical Products and Distribution segment faced losses due to higher manufacturing and welfare costs, reflecting operational challenges.
---
Ownership Overview
0.26% Insiders
20.88% Mutual Funds
0.73% Other Institutional Investors
51.31% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $93.17 and its highest was $126.23 in the past 12 months.
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $30.02B.
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Jan 30, 2025 which is in 12 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Nov 01, 2024. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.619 by $0.261.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Thriceyearly dividend of $2.015 which represents an annual dividend yield of 1.62%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is 1.76.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 242,010,500 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $1.88 in its last earnings report, beating expectations of $1.619. Following the earnings report the stock price went up 7.005%.
Which hedge fund is a major shareholder of Cardinal Health?
Currently, no hedge funds are holding shares in CAH
---
Cardinal Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$135.54 (6.70% Upside)
$135.54 (6.70% Upside)
Blogger Sentiment
Bullish
CAH Sentiment 81%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $432.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.64%
12-Months-Change
Fundamentals
Return on Equity
-38.54%
Trailing 12-Months
Asset Growth
-1.49%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
---
CAH Company Deck
---
CAH Earnings Call
Q1 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Cardinal Health delivered a strong start to fiscal 2025, marked by significant growth in the Pharma segment and improved guidance for the year. However, challenges in the GMPD segment and potential cost impacts from tariffs pose risks that could affect future performance.Read More>---
CAH Revenue Breakdown
92.59% Pharmaceutical and Specialty Solutions
5.46% Global Medical Products and Distribution
1.99% Other
---
CAH Stock 12 Month Forecast
Average Price Target
$135.54
▲(6.70% Upside)
Technical Analysis
McKesson
―
Walgreens Boots Alliance
―
Patterson Companies
―
Henry Schein
―
Owens & Minor
―
Best Analysts Covering CAH
1 Year
1 Year Success Rate
14/14 ratings generated profit
1 Year Average Return
+21.04%
reiterated a buy rating 3 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +21.04% per trade.
---